Furthermore, while a targeted reduction in PCSK9 concentrations shows promise in lowering the risk of AF, it is essential to consider the possible increased risks of developing Alzheimer's disease and asthma. Here, PCSK9 is linked to early-onset autosomal dominant Alzheimer disease.